HaoXieMDPhD

PubMed

• Improved Risk-Stratification Scheme for Mismatch-Repair Proficient Stage II Colorectal Cancers Using the Digital Pathology Biomarker QuantCRC.
  Christina Wu, Reetesh K Pai, Heidi Kosiorek, Imon Banerjee, Ashlyn Pfeiffer, Catherine E Hagen, Christopher P Hartley, Rondell P Graham, Mohamad B Sonbol, Tanios Bekai...> ;Clinical Cancer Research. 2024 May 1
• Plasma Assay of Cell-Free Methylated DNA Markers of Colorectal Cancer: A Tumor-Agnostic Approach to Monitor Recurrence and Response to Anticancer Therapies.
  Taylor, W., Mahoney, D., Then, S., Berger, C., Burger, K., Gonser, A., Doering, K., Foote, P., Kaiser, M., Allawi, H., Zhu, M., Xie, H., Hubbard, J., Kisiel, J.> ;Cancers. 2023 Dec 9
• Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer.
  Oluwadunni E Emiloju, Mojun Zhu, Hao Xie, Zhaohui Jin, Frank A Sinicrope, Joleen M Hubbard> ;Current Treatment Options in Oncology. 2023 Dec 1
• BRAF Non-V600 Mutations in Metastatic Colorectal Cancer.
  Junjia Liu, Hao Xie> ;Cancers. 2023 Sep 17
• Return to intended oncologic therapy after colectomy for stage III colon adenocarcinoma: Does surgical approach matter?
  David T Pointer Jr, Seth I Felder, Benjamin D Powers, Sophie Dessureault, Julian A Sanchez, Iman Imanirad, Ibrahim Sahin, Hao Xie, Samer A Naffouje> ;Colorectal Disease. 2023 Sep 1
• 2 citations
  Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal Cancer.
  Lingbin Meng, Ram Thapa, Maria G Delgado, Maria F Gomez, Rui Ji, Todd C Knepper, Joleen M Hubbard, Xuefeng Wang, Jennifer B Permuth, Richard D Kim, Damian A Laber, Hao...> ;JAMA Network Open. 2023 Jun 1
• 5 citations
  The intratumor microbiome is associated with microsatellite instability.
  Doratha A Byrd, Wenyi Fan, K Leigh Greathouse, Michael C Wu, Hao Xie, Xuefeng Wang> ;Journal of the National Cancer Institute. 2023 Aug 8
• 3 citations
  Translational relevance of SOS1 targeting for KRAS-mutant colorectal cancer.
  Diego Alem, Xinrui Yang, Francisca Beato, Bhaswati Sarcar, Alexandra F Tassielli, Ruifan Dai, Tara L Hogenson, Margaret A Park, Kun Jiang, Jianfeng Cai, Yu Yuan, Marti...> ;Molecular Carcinogenesis. 2023 Jul 1
• Tumor Response-speed Heterogeneity as a Novel Prognostic Factor in Patients With Metastatic Colorectal Cancer.
  Junjia Liu, Xuefeng Wang, Ibrahim H Sahin, Iman Imanirad, Seth I Felder, Richard D Kim, Hao Xie> ;American Journal of Clinical Oncology. 2023 Feb 1
• 16 citations
  Development of SOS1 Inhibitor-Based Degraders to Target-Mutant Colorectal Cancer.
  Yujia Bian, Diego Alem, Francisca Beato, Tara L Hogenson, Xinrui Yang, Kun Jiang, Jianfeng Cai, Wen Wee Ma, Martin Fernandez-Zapico, Aik Choon Tan, Nicholas J Lawrence...> ;Journal of Medicinal Chemistry. 2022 Dec 22
• 14 citations
  Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers.
  Tara L Hogenson, Hao Xie, William J Phillips, Merih D Toruner, Jenny J Li, Isaac P Horn, Devin J Kennedy, Luciana L Almada, David L Marks, Ryan M Carr, Murat Toruner, ...> ;JCI Insight. 2022 Nov 22
• 1 citations
  Phase I Study of Lenvatinib and Capecitabine with External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma.
  Rutika Mehta, Jessica Frakes, Jongphil Kim, Andrew Nixon, Yingmiao Liu, Lauren Howard, Maria E Martinez Jimenez, Estrella Carballido, Iman Imanirad, Julian Sanchez, So...> ;The Oncologist. 2022 Aug 5
• 3 citations
  Neoadjuvant rectal score is prognostic for survival: A population-based propensity-matched analysis.
  Samer A Naffouje, Nicholas Manguso, Iman Imanirad, Ibrahim H Sahin, Hao Xie, Sarah Hoffe, Jessica Frakes, Julian Sanchez, Sophie Dessureault, Seth Felder> ;Journal of Surgical Oncology. 2022 Dec 1
• 6 citations
  Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer.
  Elaine S Tan, Wenyi Fan, Todd C Knepper, Michael J Schell, Ibrahim H Sahin, Jason B Fleming, Hao Xie> ;Targeted Oncology. 2022 Jul 1
• 30 citations
  A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer.
  Richard D Kim, Maria Martinez, Hao Xie, Ibrahim H Sahin, Rutika Mehta, Jonathan Strosberg, Iman Imanirad, Masoumeh Ghayouri, Young-Chul Kim, Dae Won Kim, Kovari, B.> ;European Journal of Cancer. 2022 Jul 1
• 6 citations
  Copy Number Alterations as Novel Biomarkers and Therapeutic Targets in Colorectal Cancer.
  Elaine S Tan, Todd C Knepper, Xuefeng Wang, Jennifer B Permuth, Liang Wang, Jason B Fleming, Hao Xie> ;Cancers. 2022 Apr 29
• Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI Cancers.
  Elaine Tan, Junmin Whiting, Todd Knepper, Hao Xie, Iman Imanirad, Estrella Carballido, Seth Felder, Jessica Frakes, Qianxing Mo, Jennifer B Permuth, Katelyn Somerer, R...> ;American Journal of Clinical Oncology. 2022 Apr 1
• 5 citations
  FGFR4 inhibitors for the treatment of hepatocellular carcinoma: a synopsis of therapeutic potential.
  Hao Xie, Diego M Alem Glison, Richard D Kim> ;Expert Opinion on Investigational Drugs. 2022 Apr 1
• 1 citations
  Gastroesophageal reflux disease and paraneoplastic neurological syndrome associated with long-term survival in limited stage small-cell lung cancer.
  Vinicius Ernani, Lin Du, Helen J Ross, Joanne E Yi, Jason A Wampfler, Hao Xie, Karen L Swanson, Henry D Tazelaar, Ping Yang, Schild, S.> ;Thoracic Cancer. 2022 Apr 1
• 7 citations
  BRAF Mutations Are Associated with Poor Survival Outcomes in Advanced-stage Mismatch Repair-deficient/Microsatellite High Colorectal Cancer.
  Elaine Tan, Junmin Whiting, Hao Xie, Iman Imanirad, Estrella Carballido, Seth Felder, Jessica Frakes, Quanxing Mo, Christine Walko, Jennifer B Permuth, Katelyn Sommere...> ;The Oncologist. 2022 Mar 11
• 1 citations
  Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenoca...
  Krishnendu Pal, Tabish Hussain, Hao Xie, Shenduo Li, Ping Yang, Aaron Mansfield, Yanyan Lou, Shantanu Chowdhury, Debabrata Mukhopadhyay> ;Frontiers in Oncology. 2022 Jan 1
• 1 citations
  A Four-Gene Prognostic Signature Based on the TEAD4 Differential Expression Predicts Overall Survival and Immune Microenvironment Estimation in Lung Adenocarcinoma.
  Xiaoxia Gong, Ning Li, Chen Sun, Zhaoshui Li, Hao Xie> ;Frontiers in Pharmacology. 2022 Jan 1
• 1 citations
  SATB2 Is Expressed in a Subset of Pulmonary and Thymic Neuroendocrine Tumors.
  Julie A. Vrana, Jennifer M Boland, Simone B S P Terra, Hao Xie, Sarah M. Jenkins, Aaron S. Mansfield, Julian R. Molina, Stephen D. Cassivi, Anja C. Roden> ;American Journal of Clinical Pathology. 2021 Oct 13
• 1 citations
  Ivabradine Ameliorates Cardiac Diastolic Dysfunction in Diabetic Mice Independent of Heart Rate Reduction.
  Hao Xie, Xing-Yi Shen, Na Zhao, Peng Ye, Zhen Ge, Zuo-Ying Hu> ;Frontiers in Pharmacology. 2021 Jun 22
• 12 citations
  Locally advanced rectal adenocarcinoma: Treatment sequences, intensification, and rectal organ preservation.
  Iman Imanirad, Ibrahim Halil Sahin, Hao Xie, Jessica M. Frakes, Sarah E. Hoffe, Danielle Laskowitz, Seth Felder> ;CA. 2021 May 1
• Join now to see all

Lectures

• Phase II trial of trifluridine/tipiracil and irinotecan for the treatment of advanced refractory biliary tract cancer. 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
• Methylated DNA markers (MDMs) in primary (pCRC) and metastatic colorectal cancers (mCRC). 
  2019 ASCO Annual Meeting - 6/1/2019
• Patient-derived organoid (PDO), a new personalized therapy selection tool for prompt clinical decision making in metastatic gastrointestinal (mGI) cancer patients. 
  2019 ASCO Annual Meeting - 6/1/2019